Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1987-04-22
1990-01-02
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
2603971, 2603973, 2603974, 2603975, 514177, 514182, C07J 3100, C07J 100, A61K 31565
Patent
active
048913677
ABSTRACT:
This invention is directed to 17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related compounds and also to a method for using such compounds in the treatment of androgen-dependent disorders. The ethers are prepared by using the Simmons-Smith reaction and an appropriate vinyl ether.
REFERENCES:
patent: 3135744 (1964-06-01), Ercoli et al.
patent: 3242198 (1966-03-01), Ercoli et al.
patent: 3475464 (1969-10-01), Halpern
patent: 3732209 (1973-05-01), Fahrenholtz et al.
patent: 3763146 (1973-10-01), Edwards
patent: 4139617 (1979-02-01), Grunwell et al.
patent: 4361559 (1982-11-01), Varma
patent: 4420428 (1983-12-01), Varma
patent: 4427592 (1984-01-01), Varma
patent: 4529548 (1985-06-01), Varma
A. Ercoli et al., Chemistry and Industry, 1962, 1284.
G. Falconi, Hormonal Steroids, Proc. Intern. Cong.
Hormonal Steroids, 1st, 1964(2), 143 (1965).
R. Gardi et al., Steroids, 19, 639 (1972).
Derwent Abstract 73-73280U Netherlands Patent 73-6463.
Angelastro Michael R.
Blohm Thomas R.
Berch Mark L.
Kolano John J.
Merrell Dow Pharmaceuticals Inc.
LandOfFree
17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related com does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related com, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related com will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1383836